Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary receives registration certificate from the Ministry of Health of the Dominican Republic for injection of methylprednisolone sodium succinate.

Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Jin Yaoheping (Tianjin) Pharmaceutical Co., Ltd. (referred to as "Jin Yaoheping"), has obtained the registration certificate from the Ministry of Health of the Dominican Republic for the injection of methylprednisolone sodium succinate (referred to as "the drug"), indicating that the product can now be produced and sold in the Dominican Republic market. Methylprednisolone sodium succinate is a type of corticosteroid drug used primarily for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood disorders, tumor treatment, and shock treatment.